PRESS RELEASE published on 06/04/2024 at 12:30, 1 year 9 months ago Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels Zomedica Corp. completes expansion of global manufacturing and distribution facilities in Roswell, GA, enhancing capacity to support growing demand for veterinary health products Expansion Manufacturing Zomedica Corp. Veterinary Health Distribution Facilities
BRIEF published on 05/29/2024 at 12:35, 1 year 9 months ago Zomedica Enhances TRUFORMA® Platform With Launch of Advanced Canine Cortisol Assay Zomedica TRUFORMA Veterinary Diagnostics Canine Cortisol Assay In-house Testing
BRIEF published on 05/29/2024 at 12:35, 1 year 9 months ago Zomedica améliore la plateforme TRUFORMA® avec le lancement du test avancé de cortisol canin Zomedica TRUFORMA Diagnostic Vétérinaire Dosage Du Cortisol Canin Tests Internes
PRESS RELEASE published on 05/29/2024 at 12:30, 1 year 9 months ago Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay Zomedica Corp. strengthens market potential for its TRUFORMA in-clinic diagnostic platform with enhanced canine cortisol assay, offering improved precision and accuracy for veterinarians Zomedica Corp. Veterinary Health TRUFORMA Diagnostic Platform Canine Cortisol Assay
BRIEF published on 05/23/2024 at 12:35, 1 year 10 months ago Zomedica White Paper Unveils New Market Opportunities for PulseVet Therapy Zomedica Pulsevet Veterinary Health Equine Asthma EIPH
BRIEF published on 05/23/2024 at 12:35, 1 year 10 months ago Le livre blanc de Zomedica dévoile de nouvelles opportunités de marché pour la thérapie PulseVet Zomedica Pulsevet Santé Vétérinaire EIPH Asthme Équin
PRESS RELEASE published on 05/23/2024 at 12:30, 1 year 10 months ago Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy Zomedica Corp. releases white paper showing effectiveness of PulseVet Shock Wave therapy for equine EIPH and asthma. Promising results highlight non-invasive treatment options Zomedica Corp. Veterinary Health Equine Asthma PulseVet Therapy Equine EIPH
BRIEF published on 05/21/2024 at 12:35, 1 year 10 months ago Zomedica to Present at Lytham Partners Spring 2024 Investor Conference Investor Conference Webcast 2024 Zomedica Vet Health
BRIEF published on 05/21/2024 at 12:35, 1 year 10 months ago Zomedica fera une présentation à la conférence des investisseurs du printemps 2024 de Lytham Partners 2024 Zomedica Webdiffusion Santé Vétérinaire Conférence Des Investisseurs
PRESS RELEASE published on 05/21/2024 at 12:30, 1 year 10 months ago Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 Zomedica Corp. to participate in Lytham Partners Spring 2024 Investor Conference with webcasted presentation and 1x1 meetings for investors. Focus on veterinary health products Zomedica Corp. Veterinary Health 1x1 Meetings Lytham Partners Spring 2024 Investor Conference Webcasted Presentation
Published on 03/24/2026 at 13:30, 3 hours 20 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 3 hours 20 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 4 hours 15 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 4 hours 17 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 4 hours 20 minutes ago Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
Published on 03/24/2026 at 16:14, 36 minutes ago TenneT Germany receives preliminary inaugural S&P credit rating of BBB+ with stable outlook
Published on 03/24/2026 at 16:10, 40 minutes ago EQS-Adhoc: IONOS Group SE decides to launch new share buyback program
Published on 03/24/2026 at 16:02, 48 minutes ago EQS-Adhoc: JENOPTIK AG: Dr. Dominic Dorfner to become new CEO of JENOPTIK AG
Published on 03/24/2026 at 10:58, 5 hours 52 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 5 hours 52 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 9 hours 5 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 9 hours 5 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
